A proteomic approach to elucidate the multiple targets of selenium-induced cell-growth inhibition in human lung cancer

Thoracic Cancer

Volumn 2, Issue 4, 2011, Pages 164-178

  Zhong, Xiaorong ^a,b   Li, Lu ^a   Wang, Min ^b   Luo, Wei ^c   Tan, Qingwei ^d   Xu, Feng ^a   Zhu, Wen ^b   Wang, Qi ^d   Wang, Ting ^b   Hou, Mei ^a   Nadimity, Nagalakshmi ^c   Xue, Xingyang ^b   Chen, Jun ^b   Ma, Wei ^b   Gao, Allen C ^c   Zhou, Qinghua ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

2 D DIGE; Apoptosis; Growth inhibition; LC MS MS; Lung cancer; Methylseleninic acid

Indexed keywords

ADENOSINE TRIPHOSPHATE SYNTHASE SUBUNIT BETA; CALRETICULIN PRECURSOR; ELONGATION FACTOR 1BETA; EUKARYOTIC TRANSLATION INITIATION FACTOR 6; HEAT SHOCK PROTEIN A5; METHYLSELENINIC ACID; PROTEIN DISULFIDE ISOMERASE PRECURSOR; SELENIUM; THIOREDOXIN 1; THIOREDOXIN REDUCTASE 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; ENDOPLASMIC RETICULUM STRESS; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMAGE ANALYSIS; INTRACELLULAR SIGNALING; LIQUID CHROMATOGRAPHY; LUNG CANCER; MITOCHONDRION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; TRANSCRIPTION REGULATION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 84861366532     PISSN: 17597706     EISSN: 17597714     Source Type: Journal    
DOI: 10.1111/j.1759-7714.2011.00066.x     Document Type: Article

References (45)

1. Yang L, Li L, Chen Y, Parkin DM. [Mortality time trends and the incidence and mortality estimation and projection for lung cancer in China]. Zhongguo Fei Ai Za Zhi 2005; 8: 274-8.
2. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 2008; 83: 584-94.
3. Clark LC, Combs GF Jr, Turnbull BW etal. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996; 276: 1957-63.
4. Zhou L, Huang Y, Wang Z, Ye L, Hou W, Yang K. [Serum and lung tissue selenium measurements in subjects with lung cancer from Xuanwei, China]. Zhongguo Fei Ai Za Zhi 2011; 14: 39-42.
5. Ip C, Thompson HJ, Zhu Z, Ganther HE. In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. Cancer Res 2000; 60: 2882-6.
6. Sinha R, Unni E, Ganther HE, Medina D. Methylseleninic acid, a potent growth inhibitor of synchronized mouse mammary epithelial tumor cells in vitro. Biochem Pharmacol 2001; 61: 311-17.
7. Swede H, Dong Y, Reid M, Marshall J, Ip C. Cell cycle arrest biomarkers in human lung cancer cells after treatment with selenium in culture. Cancer Epidemiol Biomarkers Prev 2003; 12: 1248-52.
8. Liu C, Chen J, Wu Z etal. [Selenium compounds induce ROS in human high-metastatic large cell lung cancer cell line L9981]. Zhongguo Fei Ai Za Zhi 2008; 11: 354-8.
9. Liu C, Liu H, Li Y etal. Intracellular glutathione content influences the sensitivity of lung cancer cell lines to methylseleninic acid. Mol Carcinog 2011. doi: 10.1002/mc.20781.
10. Liu J, Zhong X, Zhou Q etal. [Primary experimental results of methylseleninic acid on the proliferation inhibition and apoptotic induction in human high-metastatic large cell lung cancer cell line L9981]. Zhongguo Fei Ai Za Zhi 2006; 9: 103-8.
11. Tonge R, Shaw J, Middleton B etal. Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 2001; 1: 377-96.
12. Zhou Q, Wang Y, Che G, Zhu W, Chen X, Sun Z. [Establishment and their biological characteristics of clonal cell subpopulations (NL9980 and L9981) from a human lung large cell carcinoma cell line (WCQH-9801)]. Zhongguo Fei Ai Za Zhi 2003; 6: 464-8.
13. Marouga R, David S, Hawkins E. The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem 2005; 382: 669-78.
14. Tu CJ, Dai J, Li SJ etal. High-sensitivity analysis of human plasma proteome by immobilized isoelectric focusing fractionation coupled to mass spectrometry identification. J Proteome Res 2005; 4: 1265-73.
15. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-8.
16. Navarro Silvera SA, Rohan TE. Trace elements and cancer risk: a review of the epidemiologic evidence. Cancer Causes Control 2007; 18: 7-27.
17. Li GX, Lee HJ, Wang Z etal. Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite. Carcinogenesis 2008; 29: 1005-12.
18. Kato MA, Finley DJ, Lubitz CC etal. Selenium decreases thyroid cancer cell growth by increasing expression of GADD153 and GADD34. Nutr Cancer 2010; 62: 66-73.
19. Jonsson-Videsater K, Bjorkhem-Bergman L, Hossain A etal. Selenite-induced apoptosis in doxorubicin-resistant cells and effects on the thioredoxin system. Biochem Pharmacol 2004; 67: 513-22.
20. Fernandes AP, Capitanio A, Selenius M, Brodin O, Rundlof AK, Bjornstedt M. Expression profiles of thioredoxin family proteins in human lung cancer tissue: correlation with proliferation and differentiation. Histopathology 2009; 55: 313-20.
21. Mochizuki M, Kwon YW, Yodoi J, Masutani H. Thioredoxin regulates cell cycle via the ERK1/2-cyclin D1 pathway. Antioxid Redox Signal 2009; 11: 2957-71.
22. Chen T, Wong YS. Selenocystine induces reactive oxygen species-mediated apoptosis in human cancer cells. Biomed Pharmacother 2009; 63: 105-13.
23. Rutkowski DT, Kaufman RJ. A trip to the ER: coping with stress. Trends Cell Biol 2004; 14: 20-8.
24. Lai E, Teodoro T, Volchuk A. Endoplasmic reticulum stress: signaling the unfolded protein response. Physiology (Bethesda) 2007; 22: 193-201.
25. Poerschke RL, Franklin MR, Moos PJ. Modulation of redox status in human lung cell lines by organoselenocompounds: selenazolidines, selenomethionine, and methylseleninic acid. Toxicol In Vitro 2008; 22: 1761-7.
26. Suzuki M, Endo M, Shinohara F, Echigo S, Rikiishi H. Differential apoptotic response of human cancer cells to organoselenium compounds. Cancer Chemother Pharmacol 2010; 66: 475-84.
27. Wu Y, Zhang H, Dong Y, Park YM, Ip C. Endoplasmic reticulum stress signal mediators are targets of selenium action. Cancer Res 2005; 65: 9073-9.
28. Sreedhar AS, Csermely P. Heat shock proteins in the regulation of apoptosis: new strategies in tumor therapy: a comprehensive review. Pharmacol Ther 2004; 101: 227-57.
29. Gelebart P, Opas M, Michalak M. Calreticulin, a Ca2+-binding chaperone of the endoplasmic reticulum. Int J Biochem Cell Biol 2005; 37: 260-6.
30. Bergner A, Kellner J, Tufman A, Huber RM. Endoplasmic reticulum Ca2+-homeostasis is altered in Small and non-small Cell Lung Cancer cell lines. J Exp Clin Cancer Res 2009; 28: 25.
31. Joseph P, O'Kernick CM, Othumpangat S, Lei YX, Yuan BZ, Ong TM. Expression profile of eukaryotic translation factors in human cancer tissues and cell lines. Mol Carcinog 2004; 40: 171-9.
32. Thornton S, Anand N, Purcell D, Lee J. Not just for housekeeping: protein initiation and elongation factors in cell growth and tumorigenesis. J Mol Med 2003; 81: 536-48.
33. Pincheira R, Chen Q, Zhang JT. Identification of a 170-kDa protein over-expressed in lung cancers. Br J Cancer 2001; 84: 1520-7.
34. Zhang L, Pan X, Hershey JW. Individual overexpression of five subunits of human translation initiation factor eIF3 promotes malignant transformation of immortal fibroblast cells. J Biol Chem 2007; 282: 5790-800.
35. Dong Z, Liu Z, Cui P etal. Role of eIF3a in regulating cell cycle progression. Exp Cell Res 2009; 315: 1889-94.
36. Cuezva JM, Krajewska M, de Heredia ML etal. The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res 2002; 62: 6674-81.
37. Cuezva JM, Chen G, Alonso AM etal. The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis. Carcinogenesis 2004; 25: 1157-63.
38. Isidoro A, Casado E, Redondo A etal. Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis. Carcinogenesis 2005; 26: 2095-104.
39. Santamaria G, Martinez-Diez M, Fabregat I, Cuezva JM. Efficient execution of cell death in non-glycolytic cells requires the generation of ROS controlled by the activity of mitochondrial H+-ATP synthase. Carcinogenesis 2006; 27: 925-35.
40. Howard BA, Zheng Z, Campa MJ etal. Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer. Lung Cancer 2004; 46: 313-23.
41. Yang H, Chen J, Yang J, Qiao S, Zhao S, Yu L. Cyclophilin A is upregulated in small cell lung cancer and activates ERK1/2 signal. Biochem Biophys Res Commun 2007; 361: 763-7.
42. Howard BA, Furumai R, Campa MJ etal. Stable RNA interference-mediated suppression of cyclophilin A diminishes non-small-cell lung tumor growth in vivo. Cancer Res 2005; 65: 8853-60.
43. Porter GW, Khuri FR, Fu H. Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways. Semin Cancer Biol 2006; 16: 193-202.
44. Rushworth LK, Hindley AD, O'Neill E, Kolch W. Regulation and role of Raf-1/B-Raf heterodimerization. Mol Cell Biol 2006; 26: 2262-72.
45. Qi W, Liu X, Chen W, Li Q, Martinez JD. Overexpression of 14-3-3gamma causes polyploidization in H322 lung cancer cells. Mol Carcinog 2007; 46: 847-56.